Table 1.

mRNA expression of CYP24A1 in 86 lung adenocarcinomas

Variables	N (%)	CYP24A1	P*
Normal vs. Tumor
Normal	10	6.0	<0.0001
Tumor	86	296.5
Stage
Stage I	67 (77.9)	295.5	0.96
Stage III	19 (22.1)	300.2
Classification
Bronchioloaveolar	14 (16.3)	90.7	0.001
Bronchial-derived	53 (61.6)	351.1
Others	19 (22.1)
Degree of differentiation
Poor	20 (23.5)	514.9
Moderate	42 (49.4)	303.7	0.28**
Well	23 (27.1)	104.3	0.03**
Survival status***
Dead	24 (27.9)	613.4	0.017
Alive	62 (72.1)	173.8
Median overall survival (mo)	29.5

NOTE;

^*P values calculated using t-test

^**Compared to ‘Poor’

^***Actual survival status.